Related Experiment Video
Updated: Feb 2, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Donor-specific anti-HLA antibodies by solid phase immunoassays: advantages and technical concerns
Pernille Koefoed-Nielsen1, Bjarne Kuno Møller1
1a Department of Clinical Immunology , Aarhus University Hospital , Aarhus , Denmark.
Detecting donor-specific antibodies (DSAs) is crucial for organ transplant risk assessment. While solid phase immunoassays (SPI) show prognostic value, caution is advised regarding mean fluorescence intensity (MFI) interpretation due to method limitations.
Area of Science:
- Immunology
- Transplantation Science
Background:
- Donor-specific antibodies (DSAs) are key in pre-transplant immunological risk assessment.
- Solid phase immunoassays (SPI) for DSA detection have advanced, with growing clinical evidence.
- Current interpretation of bead-based array results often relies on expert opinion due to technical limitations.
Purpose of the Study:
- To highlight the prognostic significance of SPI in organ transplant recipients with pre-existing antibodies.
- To caution against the uncritical use of mean fluorescence intensity (MFI) as a quantitative measure in transplantation.
- To review the role of SPI in detecting anti-HLA antibodies within clinical diagnostics.
Main Methods:
- Review of current literature on solid phase immunoassays (SPI) for donor-specific antibody (DSA) detection.
- Analysis of the clinical interpretation of SPI results in organ transplantation.
- Discussion of the limitations and theoretical concerns associated with SPI, particularly MFI.
Main Results:
- SPI demonstrates prognostic value in immunized organ transplant recipients.
- Mean fluorescence intensity (MFI) from SPI has documented and theoretical shortcomings for quantitative interpretation.
- Expert opinions still heavily influence clinical decisions in DSA detection for transplantation.
Conclusions:
- SPI is valuable for assessing immunological risk in organ transplantation.
- Critical evaluation of SPI results, especially MFI, is necessary for accurate clinical decision-making.
- The findings align with and provide context for the Sensitization in Transplantation: Assessment of Risk (STAR) working group report.
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Phase Diagrams
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Structures of Solids
Phase Transitions
Network Covalent Solids
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...

